White crystalline powder Polypeptide Hormone Bivalirudin Trifluoroacetate128270-60-0

Detailed Product Description

Bivalirudin Trifluoroacetate CAS 128270-60-0 For Inhibiting Thrombin-mediated Platelet Activation And Aggregation
1. Quick Detail:

Bivalirudin Trifluoroacetate
Synonym: Angiomax; BG 8967
CAS: 128270-60-0
MF: C98H138N24O33
MW: 2180.29
Purity (HPLC): 98.0%min.
Density: 1.52 g/cm3
Refractive Index: 1.675
Single Impurity (HPLC): 1.0%max
Amino Acid Composition: ± 10% of theoretical
Peptide Content (N%): >80.0%
Water Content (Karl Fischer): <8.0%
TrifluoroAcetate Content(HPIC): >12.0%
MS (ESI): Consistent
Mass Balance: 95.0~105.0%
Appearance: White powder
Grade: Pharmaceutical Grade
Storage: Closed, below 20º C preservation
Lead time: Within 12 hours upon receipt of payment
Delivery time: 4-6 working days
Delivery: EMS, DHL, TNT, FedEx, UPS
Usage: This product is mainly used for the prevention of vascular forming interventional therapy in the treatment of unstable angina, ischemic complications before and after. It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation.



2. Description:

Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a specific and reversible direct thrombin inhibitor (DTI).
Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin. It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life. It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS). It does not require a binding cofactor such as antithrombin and does not activate platelets. These characteristics make bivalirudin an ideal alternative to heparin.
Bivalirudin clinical studies demonstrated consistent positive outcomes in patients with stable angina, unstable angina (UA), non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) undergoing PCI in 7 major randomized trials.


3. Application:

Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).
Bivalirudin with provisional use of glycoprotein IIb/IIIa inhibitor (GPI) is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI).
Bivalirudin is indicated for patients with, or at risk of HIT/HITTS undergoing PCI.
Bivalirudin is intended for use with aspirin and has been studied only in patients receiving concomitant aspirin.

 

Related  products:
 

Our advantages 

High quality with competitive price

1)  Standard: Enterprise Standard

2)  We are manufacturer and can provide high quality products with factory price. 

3)  Quality can be promised. Hot sell to Worldwide.

 

 

 Fast and safe delivery

1)  Parcel can be sent out in 24 hours after payment. Tracking number available

2)  Secure and discreet shipment. Various transportation methods for your choice. 

3) We have our own agent/remailer/distributor who can help us ship our products very fast and 

  safe, and  we have stock in there for transferring. 

4)  Tracking your order at any time. Inform your order's further new situation at any time.

 

   Our clients throughout the world. 

1) Professional service and rich experience make customers feel at ease, adequate stock and 

     fast  delivery meet their desire. 

2)  Market feedback and goods feedback will be appreciated, meeting customers's requirements     our esponsibility. 

3) High quality, competitive price, fast delivery, first class service gain the trust and praise from 

   the customers.